Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | ESR1 | P03372 | 4/20 | 0.37 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.37 |
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.33 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.33 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.33 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.32 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL1478204 | 0.97 | TDP1 (0.43) | TDP1CYP3A4ESR1ESR2TAAR1 | |
| Bromide SCHEMBL29193727 | 0.97 | TDP1 (0.43) | TDP1CYP3A4ESR1ESR2TAAR1 | |
| SCHEMBL4326950 | 0.97 | TDP1 (0.43) | TDP1CYP3A4ESR1ESR2TAAR1 | |
| Bromide SCHEMBL28443974 | 0.97 | TDP1 (0.43) | TDP1CYP3A4ESR1ESR2TAAR1 | |
| Bromide SCHEMBL1582391 | 0.95 | TDP1 (0.41) | TDP1CYP3A4ESR1ESR2TAAR1 | |
| Hydrochloric Acid SCHEMBL1582634 | 0.95 | TDP1 (0.41) | TDP1CYP3A4ESR1ESR2TAAR1 | |
| SCHEMBL17414853 | 0.88 | TDP1 (0.36) | TDP1CYP3A4ESR1ESR2 | |
| SCHEMBL7542235 | 0.88 | TDP1 (0.36) | TDP1CYP3A4ESR1ESR2 | |
| Hydrochloric Acid SCHEMBL19723221 | 0.86 | CYP3A4 (0.35) | TDP1CYP3A4ESR1ESR2 | |
| Hydrochloric Acid SCHEMBL7933432 | 0.86 | CYP3A4 (0.35) | TDP1CYP3A4ESR1ESR2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 701 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12209107-B2 | Process for preparing high puritiy allopregnanolone and intermediates thereof | CRYSTAL PHARMA, S.A.U. (ES) | 2025-01-28 | — | — | US | claimed |
| WO-2025019172-A1 | ANTIMICROBIAL EXTRACTANT FORMED FROM COPPER-CONTAINING SOURCE | CORNING INCORPORATED (US) | 2025-01-23 | — | — | WO | claimed |
| CN-119192499-A | Ethylene-butadiene polymer, process for producing the same, and vulcanized rubber | 中国石油化工股份有限公司 | 2024-12-27 | — | — | CN | claimed |
| WO-2024262317-A1 | METHOD FOR PRODUCING HYDROPHILIC QUANTUM DOT | 信越化学工業株式会社 | 2024-12-26 | — | — | WO | claimed |
| CN-117964507-A | Synthesis method of polysubstituted N, N dibenzyl aniline derivative | 广西医科大学 | 2024-05-03 | — | — | CN | claimed |
| US-20230167144-A1 | PREPARATION AND ITS APPLICATION OF A CYANIDE-BRIDGED METAL ORGANIC COMPOUND WITH INTRAMOLECULAR MAGNETIC TRANSFORMATION | Hubei Jingmen Industrial Technology Research Institute Co., Ltd. (CN) | 2023-06-01 | — | — | US | claimed |
| CN-115650880-A | Recycling method of MDI with over-shelf life, method for preparing carbodiimide modified isocyanate from MDI with over-shelf life and product | 万华化学（宁波）有限公司 | 2023-01-31 | — | — | CN | claimed |
| CN-111518145-A | Cyanide-bridged metal organic compound with intramolecular magnetic transformation, and preparation method and application thereof | 荆楚理工学院 | 2020-08-11 | — | — | CN | claimed |
| CN-107488113-B | Method for synthesizing o-aminobiphenyl compound | 上海泰禾国际贸易有限公司 | 2020-05-12 | — | — | CN | claimed |
| WO-2019016115-A1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED ARYL KETONES | BASF Agro B.V. (NL) | 2019-01-24 | — | — | WO | claimed |
| US-5563014-A | SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | claimed |
| US-5514505-A | SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE | XEROX CORPORATION (US) | 1996-05-07 | — | — | US | claimed |
| EP-0370563-B1 | PREPARATION OF CONJUGATED DIENES | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1993-05-19 | — | — | EP | claimed |
| US-4943670-A | Hydroisomerization | SHELL OIL COMPANY (US) | 1990-07-24 | — | — | US | claimed |
| EP-0370563-A1 | Preparation of conjugated dienes | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1990-05-30 | — | — | EP | claimed |
| EP-0028378-B1 | IMPROVED HYDROFORMYLATION PROCESS USING STABLE RHODIUM CATALYST | UNION CARBIDE CORPORATION (US) | 1985-01-09 | — | — | EP | claimed |
| US-4283562-A | COMPLEXED WITH CARBON MONOXIDE AND A PHENYL PHOSPHINE | UNION CARBIDE CORPORATION (US) | 1981-08-11 | — | — | US | claimed |
| EP-0028378-A1 | Improved hydroformylation process using stable rhodium catalyst | UNION CARBIDE CORPORATION (US) | 1981-05-13 | — | — | EP | claimed |
| US-4201728-A | RHODIUM METAL COMPLEX CATALYST | CELANESE CORPORATION (US) | 1980-05-06 | — | — | US | claimed |
| US-4169861-A | STAVILIZED RHODIUM METAL BIDENTATE LIGAND AND MONODENTATE LIGAND | CELANESE CORPORATION (US) | 1979-10-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12209107-B2 | Process for preparing high puritiy allopregnanolone and intermediates thereof | CYP21A2, CYP17A1, CYP11B1 | TDP1 4026/4885CYP3A4 62/4885ESR1 558/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.